
BIOCONVERGENCE &
REGULATORY
Accelerating Innovation in Therapeutics
A unique online program from Tel Aviv University for biotech and health-tech professionals who want to lead the next generation of medical innovation
Ready to accelerate your innovation?
Gain essential insights into developing next-generation therapeutics.
WHO IS IT FOR
This program is tailored for professionals in biotechnology, life sciences, engineering, digital health, and medicine
Scientists and R&D professionals
Physicians and Clinical researchers
Product innovators and entrepreneurs
Regulatory and project managers
Entrepreneurs and BD in health tech
If you are developing novel therapeutics (bioconvergence products) - where biology, technology, data science and AI meet—this program will equip you with the regulatory and scientific foundations to bring them successfully to market.
ABOUT THE PROGRAM
Bioconvergence & Regulation: Accelerating Innovation in Therapeutics is a 4-course online program
This progam was created by leading scientists at the Gray Faculty of Health and Medical Sciences of Tel Aviv University, in collaboration with center for TAU Innovation in Education.
Taught by leading experts
Includes interviews with lecturers
Practical case studies & self-assessment quizzes
Certificate from Tel Aviv University
Introducing the program >>
This program gave me the confidence to lead regulatory strategy in our biotech startup.
Dr. Sarah Levine
Regulatory Affairs Lead
THE PROGRAM
This educational program is a series of advanced online courses, designed for scientists in the biotech industry who are driving innovation at the intersection of biology, technology, and regulation.
Gain essential insights into the scientific foundations and regulatory pathways that shape the development of next-generation therapeutics.
THE COURSES
The four courses were designed to complement each other , by taking all four courses you will gain a comprehensive understanding of the process of development and regulation of novel medical technologies
MEET THE EXPERTS
The program, led by Dr. Michal Roll and Prof. Noam Shomron, bridges two worlds that rarely meet — science and regulation.
Michal brings deep expertise in health policy, ethics, and regulation, while Noam contributes his experience as a genomics researcher, entrepreneur, and innovator in the biotech and digital health space.
Together, they designed a program that trains the next generation of leaders who can both develop and responsibly implement medical technologies that truly impact patients’ lives.
Dr. Michal Roll and Prof. Noam Shomron
Co-Heads, Master’s Program in Development and Regulation of Medical Technologies
CORE OF LEADING EXPERTS
Michal brings deep expertise in health policy, ethics, and regulation, while Noam contributes his experience as a genomics researcher,
NAME
NAME NAMER
NAME NAME
NAMEE
WHY CHOOSE THIS PROGRAM?
Comprehensive understanding of the regulatory process for novel therapeutics
Learn from world- renowned experts in science and regulation
Exclusive interviews with lecturers sharing real-world insights
Self-assessment quizzes and practical case studies
Study at your own pace with academic support and teaching assistants
Earn a certificate from Tel Aviv University
Bonus for students who complete all four course
Participate in a practicum, virtually applying their own product through the stages of development and regulation, with feedback from the course directors.
This program gave me the confidence to lead regulatory strategy in our biotech startup.
Dr. Sarah Levine
Regulatory Affairs Lead
SCHEDULING & PRICING
Price of the program (all 4 courses)
$7000*
COURSE 1: November 17th, 2025
COURSE 2: January 11th, 2026
COURSE 3: April 12th, 2026
COURSE 4: June 14th, 2026
Each individual course: $2,000
*Registration by 30 Nov 2026
SPECIAL OFFER
Personal practicum for students who complete all four courses
You will be able to virtually apply your own product through the stages of development and regulation and receive valuable feedback from the course directors

